Concepedia

Publication | Open Access

Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study

106

Citations

28

References

2014

Year

Abstract

ClinicalTrials.gov NCT00573326. Registered 13 December 2007.

References

YearCitations

Page 1